UPDATED May 18, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GTC | UK£0.099 | 9.7% | -34.2% | UK£6.7m | n/a | PS1.6x | E86.1% | 0% | Energy | ||
GKP | UK£1.34 | 11.9% | 1.6% | UK£297.7m | UK£1.53 | PS3.1x | E54.6% | 0% | Energy | ||
PFC | UK£0.10 | 0% | -85.5% | UK£54.7m | n/a | PE-0.1x | E115.4% | 0% | Energy | ||
SPSY | UK£2.50 | 8.2% | 47.1% | UK£119.5m | UK£3.52 | PE25.1x | E26.3% | 3.7% | Tech | ||
ENOG | UK£11.85 | -1.0% | 8.1% | UK£2.2b | UK£14.62 | PE14.9x | E21.7% | 8.0% | Energy | ||
TEAM | UK£0.19 | 0% | -52.5% | UK£7.5m | n/a | PS1.4x | E58.6% | n/a | Diversified Financials | ||
AET | UK£0.54 | 5.5% | 87.7% | UK£117.9m | n/a | PB3.3x | E198.2% | n/a | Energy | ||
VEL | UK£0.40 | 6.7% | 2.6% | UK£21.4m | n/a | PS1.3x | E140.5% | 0% | Capital Goods | ||
PHC | UK£0.057 | 35.8% | -43.5% | UK£19.3m | n/a | PS2.1x | E94.4% | n/a | Materials | ||
IDHC | US$0.32 | -2.3% | -31.1% | US$192.3m | n/a | PE17.7x | E27.9% | n/a | Healthcare | ||
FSG | UK£4.52 | -1.1% | 7.6% | UK£523.9m | UK£5.95 | PE25x | E30.9% | 4.9% | Diversified Financials | ||
B90 | UK£0.029 | 7.3% | -65.9% | UK£8.3m | n/a | PS3.2x | E142.7% | 0% | Consumer Services | ||
LSL | UK£3.05 | 3.4% | 10.1% | UK£315.1m | UK£3.69 | PE38.9x | E33.3% | 3.7% | Real Estate Management and Development | ||
JDG | UK£116.50 | -2.9% | 24.2% | UK£773.6m | UK£128.52 | PE81.4x | E25.3% | 0.8% | Capital Goods | ||
MEX | UK£0.52 | 5.1% | -49.8% | UK£19.9m | UK£1.05 | PB6.9x | E79.5% | n/a | Consumer Services | ||
BKS | UK£1.76 | 1.4% | 48.5% | UK£117.1m | UK£2.60 | PE198.4x | E57.9% | 0% | Software | ||
DXRX | UK£1.15 | 18.7% | 33.9% | UK£96.7m | UK£1.67 | PE16116.2x | E41.2% | n/a | Pharmaceuticals & Biotech | ||
EVOK | UK£0.89 | 3.5% | 16.1% | UK£401.5m | UK£1.31 | PB5x | E72.4% | 0% | Consumer Services | ||
FTC | UK£0.58 | 0% | 373.5% | UK£125.9m | n/a | PS7.7x | E133.3% | n/a | Tech | ||
EAAS | UK£0.064 | -8.0% | 16.5% | UK£24.6m | n/a | PS1.4x | E91.1% | n/a | Commercial Services | ||
FUM | UK£0.40 | 0% | -7.2% | UK£119.7m | UK£1.26 | PS38.6x | E111.8% | n/a | Pharmaceuticals & Biotech | ||
TPFG | UK£3.93 | -1.9% | 25.6% | UK£244.6m | UK£4.96 | PE33.1x | E36.7% | 3.1% | Real Estate Management and Development | ||
KIST | UK£1.47 | -15.6% | -43.2% | UK£121.4m | UK£4.36 | PB1.7x | E88.1% | n/a | Energy | ||
LLAI | UK£0.21 | -17.3% | -56.1% | UK£6.6m | UK£2.20 | PS182.1x | E88.7% | n/a | Pharmaceuticals & Biotech |